BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1362727)

  • 1. The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells.
    Chadburn A; Inghirami G; Knowles DM
    Hematol Pathol; 1992; 6(4):193-202. PubMed ID: 1362727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell activation-associated antigen expression by neoplastic T-cells.
    Chadburn A; Inghirami G; Knowles DM
    Hematol Pathol; 1992; 6(3):131-41. PubMed ID: 1429341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland.
    Bisset LR; Lung TL; Kaelin M; Ludwig E; Dubs RW
    Eur J Haematol; 2004 Mar; 72(3):203-12. PubMed ID: 14962239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
    Glasová M; Koníková E; Stasáková J; Babusíková O
    Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
    Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
    J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
    Klobusická M; Babusíková O
    Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the continuous recruitment and activation of T cells into the joints of patients with rheumatoid arthritis.
    Iannone F; Corrigall VM; Kingsley GH; Panayi GS
    Eur J Immunol; 1994 Nov; 24(11):2706-13. PubMed ID: 7957563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
    Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
    Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease.
    Baker C; Chang L; Elsegood KA; Bishop AJ; Gannon DH; Narendran P; Leech NJ; Dayan CM
    Clin Exp Immunol; 2007 Mar; 147(3):472-82. PubMed ID: 17302896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
    Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
    Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells.
    Ellis TM; Simms PE; Slivnick DJ; Jäck HM; Fisher RI
    J Immunol; 1993 Sep; 151(5):2380-9. PubMed ID: 8103064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative study of the expression of activation markers on T-lymphocyte subpopulations in different forms of bronchial asthma].
    Beda MV; Pavliuk AS; Veselova AV; Dement'eva EG; Solov'ev SS; Bart BIa; Koval'chuk LV
    Ter Arkh; 1995; 67(3):26-9. PubMed ID: 7770797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of some activation/proliferation markers on human thymocytes and their correlation with cell proliferation.
    Babusíková O; Ondrácková V; Prachar J; Kusenda J; Hraska V
    Neoplasma; 1999; 46(6):349-55. PubMed ID: 10732863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
    Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
    J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of HLA-DR antigen expression in phytohemagglutinin-activated T cells in man. Requirement of T cell recognition of self HLA-DR antigen expressed on the surface of monocytes.
    Moriya N; Sanjoh K; Yokoyama S; Hayashi T
    J Immunol; 1987 Nov; 139(10):3281-6. PubMed ID: 3500214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
    Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
    J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene.
    Takahata Y; Nomura A; Takada H; Ohga S; Furuno K; Hikino S; Nakayama H; Sakaguchi S; Hara T
    Exp Hematol; 2004 Jul; 32(7):622-9. PubMed ID: 15246158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pattern of activation antigen expression on T-lymphocyte subpopulation in infectious mononucleosis.
    Pálóczi K; Pócsik E; Kotlán B; Ujhelyi E; Timár L; Petrányi GG
    Haematologia (Budap); 1991; 24(2):83-90. PubMed ID: 1840056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients.
    Vlková M; Thon V; Sárfyová M; Bláha L; Svobodník A; Lokaj J; Litzman J
    Clin Exp Immunol; 2006 Feb; 143(2):373-9. PubMed ID: 16412063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.